DEFA14A: Atea Pharmaceuticals Sets Date for 2024 Annual Meeting, Outlines Voting Matters

Atea Pharmaceuticals announces its 2024 Annual Meeting of Stockholders to be held virtually on June 21, 2024, outlining key voting items including the election of directors and ratification of the company's independent auditor.

Summary

• Atea Pharmaceuticals has scheduled its Annual Meeting of Stockholders for June 21, 2024, at 9:00 AM EDT.
• The meeting will be held virtually at www.virtualshareholdermeeting.com/AVIR2024.
• Stockholders are entitled to vote on several key proposals.
• These include the election of Franklin Berger and Jean-Pierre Sommadossi, Ph.D. as Class I Directors.
• Another proposal is the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• Additionally, stockholders will vote on an advisory basis regarding the compensation of the company's named executive officers.
• Proxy materials, including the Notice, Proxy Statement, and Form 10-K, are available online.
• Stockholders can request a free paper or email copy of these materials before June 7, 2024.
• The control number for voting is V49572-P07588.
• The deadline to vote is June 20, 2024, at 11:59 PM ET.

Sentiment

Score: 5

Explanation: The document is a standard proxy statement, so the sentiment is neutral.

Positives

• The virtual format of the meeting allows for broader accessibility for stockholders.
• Stockholders have the opportunity to influence key decisions through voting on director elections, auditor ratification, and executive compensation.

Future Outlook

The document outlines the procedural steps for the upcoming annual meeting, but does not contain any forward-looking statements about the company's future performance or strategic direction.

Industry Context

This announcement is a standard corporate governance procedure for publicly traded companies, ensuring shareholders have the opportunity to participate in key decisions.

Stakeholder Impact

• Shareholders can vote on key company matters.
• The selection of directors and auditors impacts the company's governance and financial oversight.

Next Steps

• Stockholders should review the proxy materials.
• Stockholders should vote on the proposals by the deadline of June 20, 2024.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Vote, Directors, KPMG, Executive Compensation, AVIR, ATEA Pharmaceuticals